A Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders
Year: 1997
Type: article
Source: Drug Safety
Author: John C. Pecknold
Institution: Douglas Mental Health University Institute
Language: English
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2013161512
